Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1551)
All Articles published online
|
Nov 21, 2007 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: Experimental findings and clinical implications. World J Gastroenterol 2007; 13(43): 5682-5686 [PMID: 17963292 DOI: 10.3748/wjg.v13.i43.5682] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i43/5682.htm |
| Number | Citing Articles |
| 1 |
Marion Levast, Sylvie Larrat, Marie‐Ange Thelu, Sandrine Nicod, Agnès Plages, Alice Cheveau, Jean‐Pierre Zarski, Jean‐Marie Seigneurin, Patrice Morand, Vincent Leroy. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. Journal of Medical Virology 2010; 82(5): 747 doi: 10.1002/jmv.21695
|
| 2 |
Patricia M. Mulrooney-Cousins, Ranjit Chauhan, Norma D. Churchill, Tomasz I. Michalak, Aleem Siddiqui. Primary Seronegative but Molecularly Evident Hepadnaviral Infection Engages Liver and Induces Hepatocarcinoma in the Woodchuck Model of Hepatitis B. PLoS Pathogens 2014; 10(8): e1004332 doi: 10.1371/journal.ppat.1004332
|
| 3 |
R. A. A. Pondé. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(9): 1709 doi: 10.1007/s10096-015-2422-x
|
| 4 |
Amadin A. Olotu, Adesola O. Oyelese, Lateef Salawu, Rosemary A. Audu, Azuka P. Okwuraiwe, Aaron O. Aboderin. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virology Journal 2016; 13(1) doi: 10.1186/s12985-016-0533-3
|
| 5 |
|
| 6 |
E-H Park, S S Koh, R Srisuttee, I-R Cho, H-J Min, B H Jhun, Y-S Lee, K L Jang, C-H Kim, R N Johnston, Y-H Chung. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Cancer Gene Therapy 2009; 16(5): 453 doi: 10.1038/cgt.2008.95
|
| 7 |
Tomasz I. Michalak, Hong Zhang, Norma D. Churchill, Torbjörn Larsson, Nils-Gunnar Johansson, Bo Öberg. Profound Antiviral Effect of Oral Administration of MIV-210 on Chronic Hepadnaviral Infection in a Woodchuck Model of Hepatitis B. Antimicrobial Agents and Chemotherapy 2009; 53(9): 3803 doi: 10.1128/AAC.00263-09
|
| 8 |
Hui-Lan Zhu, Xu Li, Jun Li, Zhen-Hua Zhang. Genetic variation of occult hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(13): 3531-3546 doi: 10.3748/wjg.v22.i13.3531
|
| 9 |
Giovanni Raimondo, Stephen Locarnini, Teresa Pollicino, Massimo Levrero, Fabien Zoulim, Anna S. Lok, Jean-Pierre Allain, Thomas Berg, Antonio Bertoletti, Maurizia Rossana Brunetto, Raffaele Bruno, Ding-Shinn Chen, Nicola Coppola, Markus Cornberg, Antonio Craxì, Maura Dandri, Vito Di Marco, Carlo Ferrari, Giovanni Battista Gaeta, Dieter Glebe, Luca G. Guidotti, Anna Kramvis, Pietro Lampertico, Chengyao Li, Jake Liang, Alfredo Marzano, Thomas I. Michalak, Jean-Michel Pawlotsky, Daniele Prati, Massimo Puoti, Didier Samuel, Vincent Soriano, Giovanni Squadrito, Camille Sureau, Christian Trepo, Man-Fung Yuen. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. Journal of Hepatology 2019; 71(2): 397 doi: 10.1016/j.jhep.2019.03.034
|
| 10 |
Emilio D'Ugo, Claudio Argentini, Roberto Giuseppetti, Andrea Canitano, Stefania Catone, Maria Rapicetta. The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies. Expert Opinion on Drug Discovery 2010; 5(12): 1153 doi: 10.1517/17460441.2010.530252
|
| 11 |
Shashi A. Gujar, Adam K.M. Jenkins, Sonya A. MacParland, Tomasz I. Michalak. Pre-acute hepadnaviral infection is associated with activation-induced apoptotic death of lymphocytes in the woodchuck (Marmota monax) model of hepatitis B. Developmental & Comparative Immunology 2010; 34(9): 999 doi: 10.1016/j.dci.2010.05.001
|
| 12 |
Ying Lu, Ya-Lin Liu, Jing-Jing Nie, Xiao-Feng Liang, Ling Yan, Fu-Zhen Wang, Xiang-Jun Zhai, Jian-Xun Liu, Feng-Cai Zhu, Zhan-Jun Chang, Jie Li, Antonio Bertoletti. Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study. PLOS ONE 2016; 11(11): e0166317 doi: 10.1371/journal.pone.0166317
|
| 13 |
Yi-Ming Chen, Sheng-Shun Yang, Der-Yuan Chen. Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review. Journal of Microbiology, Immunology and Infection 2019; 52(1): 1 doi: 10.1016/j.jmii.2017.10.002
|
| 14 |
Min-Sun Kwak, Yoon Jun Kim. Occult hepatitis B virus infection. World Journal of Hepatology 2014; 6(12): 860-869 doi: 10.4254/wjh.v6.i12.860
|
| 15 |
So Young Jang, Mi Suk Kim, Min Seok Park, Keon Myung Lee, Hwan Won Chung, Jongsik Chun, Chan Hee Lee. Designing primers from multiple sequences using matchup program to improve detection of hepatitis B virus by polymerase chain reaction. The Journal of Microbiology 2010; 48(1): 111 doi: 10.1007/s12275-009-0282-8
|
| 16 |
Shashi A. Gujar, Adam K. Jenkins, Clifford S. Guy, Jinguo Wang, Tomasz I. Michalak. Aberrant Lymphocyte Activation Precedes Delayed Virus-Specific T-Cell Response after both Primary Infection and Secondary Exposure to Hepadnavirus in the Woodchuck Model of Hepatitis B Virus Infection. Journal of Virology 2008; 82(14): 6992 doi: 10.1128/JVI.00661-08
|
| 17 |
|
| 18 |
Roberto Cangemi, Marzia Miglionico, Stefania Basili. Infections as predictors of NAFLD progression. Internal and Emergency Medicine 2022; 17(8): 2185 doi: 10.1007/s11739-022-03096-5
|
| 19 |
Selam Bogale Gissa, Mengistu Erkie Minaye, Biruk Yeshitela, Gizachew Gemechu, Abebech Tesfaye, Dawit Hailu Alemayehu, Abel Shewaye, Amir Sultan, Adane Mihret, Andargachew Mulu. Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, Addis Ababa Ethiopia. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17336-3
|
| 20 |
IL-RAE CHO, MYUNGJU OH, SANG SEOK KOH, WARAPORN MALILAS, RATAKORN SRISUTTEE, BYUNG HAK JHUN, SANDRA PELLEGRINI, SERGE Y. FUCHS, YOUNG-HWA CHUNG. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor. International Journal of Molecular Medicine 2012; 29(4): 581 doi: 10.3892/ijmm.2012.879
|
| 21 |
R. Cassini, M. S. De Mitri, D. Gibellini, L. Urbinati, S. Bagaglio, G. Morsica, M. Domenicali, G. Verucchi, M. Bernardi. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV‐infected individuals with occult HBV infection. Journal of Viral Hepatitis 2013; 20(1): 42 doi: 10.1111/j.1365-2893.2012.01623.x
|
| 22 |
Giovanni Raimondo, Jean-Pierre Allain, Maurizia R. Brunetto, Marie-Annick Buendia, Ding-Shinn Chen, Massimo Colombo, Antonio Craxì, Francesco Donato, Carlo Ferrari, Giovanni B. Gaeta, Wolfram H. Gerlich, Massimo Levrero, Stephen Locarnini, Thomas Michalak, Mario U. Mondelli, Jean-Michel Pawlotsky, Teresa Pollicino, Daniele Prati, Massimo Puoti, Didier Samuel, Daniel Shouval, Antonina Smedile, Giovanni Squadrito, Christian Trépo, Erica Villa, Hans Will, Alessandro R. Zanetti, Fabien Zoulim. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008; 49(4): 652 doi: 10.1016/j.jhep.2008.07.014
|
| 23 |
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment. Journal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
|
| 24 |
Shashi A. Gujar, Tomasz I. Michalak. Primary Occult Hepadnavirus Infection Induces Virus-Specific T-Cell and Aberrant Cytokine Responses in the Absence of Antiviral Antibody Reactivity in the Woodchuck Model of Hepatitis B Virus Infection. Journal of Virology 2009; 83(8): 3861 doi: 10.1128/JVI.02521-08
|
| 25 |
Ying-Hui Shi, Chang-He Shi. Molecular characteristics and stages of chronic hepatitis B virus infection. World Journal of Gastroenterology 2009; 15(25): 3099-3105 doi: 10.3748/wjg.15.3099
|
| 26 |
S. Boumbaly, T.A. L. Balde, A. V. Semenov, Yu. V. Ostankova, E. N. Serikova, E. V. Naidenova, D. E. Valutite, A. N. Shchemelev, E. B. Zueva, E. V. Esaulenko, Areg A. Totolian. Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea. Problems of Virology 2022; 67(1): 59 doi: 10.36233/0507-4088-92
|
| 27 |
Maria Stella De Mitri, Romina Cassini, Mauro Bernardi. Hepatitis B virus-related hepatocarcinogenesis: Molecular oncogenic potential of clear or occult infections. European Journal of Cancer 2010; 46(12): 2178 doi: 10.1016/j.ejca.2010.03.034
|
| 28 |
Vicente Carreño*, Javier Bartolomé, Inmaculada Castillo, Juan Antonio Quiroga. Occult hepatitis B virus and hepatitis C virus infections. Reviews in Medical Virology 2008; 18(3): 139 doi: 10.1002/rmv.569
|
| 29 |
Shivali S. Joshi, Carla S. Coffin. Hepatitis B virus lymphotropism: emerging details and challenges. Biotechnology and Genetic Engineering Reviews 2018; 34(1): 139 doi: 10.1080/02648725.2018.1474324
|
| 30 |
Tomasz I. Michalak. Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00853
|
| 31 |
Assem El-Sherif, Mohamed Abou-Shady, Hany Abou-Zeid, Ahmed Elwassief, Ashraf Elbahrawy, Yoshihide Ueda, Tsutomu Chiba, Abdel-Moneim Hosney. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. Journal of Gastroenterology 2009; 44(4): 359 doi: 10.1007/s00535-009-0020-3
|
| 32 |
C. S. Coffin, P. M. Mulrooney-Cousins, M. G. Peters, G. van Marle, J. P. Roberts, T. I. Michalak, N. A. Terrault. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. Journal of Viral Hepatitis 2011; 18(6): 415 doi: 10.1111/j.1365-2893.2010.01321.x
|
| 33 |
Georget Y. Reaiche, Marc F. Le Mire, William S. Mason, Allison R. Jilbert. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology 2010; 406(2): 286 doi: 10.1016/j.virol.2010.07.013
|
| 34 |
Yu. V. Ostankova, A. V. Semenov, Z. K. Burkitbayev, T. N. Savchuk, A. A. Totolian. RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN. Russian Journal of Infection and Immunity 2018; 7(4): 383 doi: 10.15789/2220-7619-2017-4-383-392
|
| 35 |
Ramazan Idilman, Mutlu Arat. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Review of Anti-infective Therapy 2011; 9(8): 641 doi: 10.1586/eri.11.79
|
| 36 |
Shashi A. Gujar, Patricia M. Mulrooney-Cousins, Tomasz I. Michalak. Repeated Exposure to Trace Amounts of Woodchuck Hepadnavirus Induces Molecularly Evident Infection and Virus-Specific T Cell Response in the Absence of Serological Infection Markers and Hepatitis. Journal of Virology 2013; 87(2): 1035 doi: 10.1128/JVI.01363-12
|
| 37 |
Birama Diarra, Abdoul Karim Ouattara, Florencia Wendkuuni Djigma, Tegwinde Rebeca Compaore, Dorcas Obiri-Yeboah, Lassina Traore, Serge Theophile Soubeiga, Prosper Bado, Justine Yara, Virginio Pietra, Paul Ouedraogo, Alain Bougouma, Rokia Sanogo, Jacques Simpore. World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination. Hepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.13789
|
| 38 |
Carlo Saitta, Teresa Pollicino, Giovanni Raimondo. Occult Hepatitis B Virus Infection: An Update. Viruses 2022; 14(7): 1504 doi: 10.3390/v14071504
|
| 39 |
Giovanni Raimondo, Gaia Caccamo, Roberto Filomia, Teresa Pollicino. Occult HBV infection. Seminars in Immunopathology 2013; 35(1): 39 doi: 10.1007/s00281-012-0327-7
|
| 40 |
Yi‐Ming Chen, Hsin‐Hua Chen, Wen‐Nan Huang, Yi‐Hsing Chen, Tsu‐Yi Hsieh, Sheng‐Shun Yang, Joung‐Liang Lan, Der‐Yuan Chen. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation. International Journal of Rheumatic Diseases 2019; 22(6): 1145 doi: 10.1111/1756-185X.13582
|
| 41 |
Paul Schmeltzer, Kenneth E. Sherman. Occult Hepatitis B: Clinical Implications and Treatment Decisions. Digestive Diseases and Sciences 2010; 55(12): 3328 doi: 10.1007/s10620-010-1413-0
|
| 42 |
Suda Louisirirotchanakul, Sineenart Oota, Kalayanee Khuponsarb, Wilai Chalermchan, Soisaang Phikulsod, Viroje Chongkolwatana, Tasanee Sakuldamrongpanish, Pimpun Kitpoka, Pimol Chielsilp, Srivilai Tanprasert, Thaweesak Tirawatnapong, Chantapong Wasi. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011; 51(7): 1532 doi: 10.1111/j.1537-2995.2010.03023.x
|
| 43 |
C. Pande, S. K. Sarin, S. Patra, A. Kumar, S. Mishra, S. Srivastava, K. Bhutia, E. Gupta, C. K. Mukhopadhyay, A. K. Dutta, S. S. Trivedi. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg‐positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. Journal of Viral Hepatitis 2013; 20(11): 801 doi: 10.1111/jvh.12102
|
| 44 |
Hepatitis B virus preCore/Core region variability in pregnant women in the Republic of Guinea. Journal of microbiology, epidemiology and immunobiology 2024; 101(1): 61 doi: 10.36233/0372-9311-447
|
| 45 |
C.S. Coffin, P.G. Stock, L.M. Dove, C.L. Berg, N.N. Nissen, M.P. Curry, M. Ragni, F.G. Regenstein, K.E. Sherman, M.E. Roland, N.A. Terrault. HBV and HIV Coinfection and Liver Transplant. American Journal of Transplantation 2010; 10(5): 1268 doi: 10.1111/j.1600-6143.2010.03070.x
|
| 46 |
Michael Nassal. Hepatitis B viruses: Reverse transcription a different way. Virus Research 2008; 134(1-2): 235 doi: 10.1016/j.virusres.2007.12.024
|
| 47 |
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and Management. Hepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/259148
|
| 48 |
Atul K. Sood, Sukant M. Pathak, Nitish Khandelwal. A Study of Prevalence of Occult Hepatitis B Virus Infection, Knowledge and Preventive Practices Against Hepatitis B Virus in Barbers Serving the Armed Forces. Journal of Clinical and Experimental Hepatology 2021; 11(6): 668 doi: 10.1016/j.jceh.2021.02.005
|
| 49 |
Giovanni Raimondo, Teresa Pollicino. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; : 277 doi: 10.1007/978-3-319-22330-8_13
|
| 50 |
YuQiong Li, Hui Wang, DaPeng Li, JingYi Hu, Hao Wang, DongXun Zhou, QiaoMei Li, XiaoLan Jiang, HuaBang Zhou, HePing Hu. Occult Hepatitis B Virus Infection in Chinese Cryptogenic Intrahepatic Cholangiocarcinoma Patient Population. Journal of Clinical Gastroenterology 2014; 48(10): 878 doi: 10.1097/MCG.0000000000000058
|
| 51 |
Sang Hee Song, Seong Gyu Hwang. Occult Hepatitis B Virus Infection: Transmission and Reactivation. The Korean Journal of Gastroenterology 2013; 62(3): 148 doi: 10.4166/kjg.2013.62.3.148
|
| 52 |
Francisca Sosa-Jurado, Nora Hilda Rosas-Murrieta, Belinda Guzman-Flores, Cintia Perez Zempoaltecalt, Ana Patricia Sanchez Torres, Leticia Ramirez Rosete, Maribel Bernal-Soto, Luis Marquez-Dominguez, Daniel Melendez-Mena, Miguel Angel Mendoza Torres, Maria Teresa Lopez Delgado, Julio Reyes-Leyva, Veronica Vallejo-Ruiz, Gerardo Santos-Lopez. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA. Hepatitis Monthly 2016; 16(6) doi: 10.5812/hepatmon.36942
|
| 53 |
Mitra Ranjbar, Masoumeh Dadkhah, Farah Bokharaei Salim, Marzieh Daneshbodi, Shokoufeh Savaj, Hossein Keyvani. The Prevalence of Occult HBV Infection Among Hemodialysis Patients of Tehran, Iran. Modern Care Journal 2017; 14(4) doi: 10.5812/modernc.65546
|
| 54 |
Peter B Sugden, Barbara Cameron, Rowena Bull, Peter A White, Andrew R Lloyd. Occult infection with hepatitis C virus: friend or foe?. Immunology & Cell Biology 2012; 90(8): 763 doi: 10.1038/icb.2012.20
|